NCT07212738

Brief Summary

The purpose of this research study is to better understand when to start rehabilitation therapies after acute ischemic stroke to prevent further harm to the brain and to improve outcomes for stroke survivors. Stroke is the second leading cause of death and reduced quality of life worldwide, with one Canadian diagnosed with stroke every five minutes. The most common subtype, ischemic stroke, occurs when a blood vessel in the brain is blocked. Hyperacute treatments aim to remove these blockages to restore blood flow and improve deficits, but in some cases, this is not achieved and leads to persistent large or medium intracranial vessel occlusion. After stroke, early medical and physical care can reduce physical and cognitive impairment and improve long-term functional outcomes. Prolonged immobilization can cause secondary complications and make recovery more difficult. Other research studies have demonstrated varying results with both benefit and no difference in the long-term level of functional independence when starting physical activity between 24 to 48 hours after acute ischemic stroke. The optimal timing for mobilization is unclear especially for patients with persistent vessel occlusion large stroke size, or intracranial hemorrhage, where starting active therapy too soon can cause additional harm by damaging the brain further. In this research study, the investigators aim to evaluate the feasibility and effect of delayed mobilization (DeM), defined as physical therapy starting on or after day 3 from stroke symptom onset, on stroke volume growth and functional outcomes in patients with persistent vessel occlusion. The investigators think that individuals who still have evidence of persistent blockage in their arteries may benefit from waiting until day 3 after stroke to begin rehabilitation. Improving care strategies for stroke survivors will ultimately benefit individuals, their families, and healthcare systems. This study may guide the optimal timing of initiating stroke rehabilitation in patients with persistent vessel occlusion and ischemia to improve recovery times and reduce long-term disabilities.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
7mo left

Started Oct 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Oct 2025Nov 2026

First Submitted

Initial submission to the registry

September 23, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

October 8, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

October 15, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

October 8, 2025

Status Verified

October 1, 2025

Enrollment Period

12 months

First QC Date

September 23, 2025

Last Update Submit

October 1, 2025

Conditions

Keywords

strokerehabilitationneuroimaging

Outcome Measures

Primary Outcomes (1)

  • Feasibility of delayed mobilization.

    Our primary outcome will be completion of the trial to determine whether delaying mobilization is feasible.

    Participants will be assessed for up to 3 months post-stroke, predominantly on their 7 day admission and at their 3-month outpatient follow-up (8 total days).

Secondary Outcomes (1)

  • Incidence of secondary neurovascular injury.

    Neuroimaging outcomes will be compared from admission (day 1-2 post-stroke) to repeat MRI on day 7.

Other Outcomes (1)

  • Rate of functional independence.

    Participants will be assessed for up to 3 months post-stroke, predominantly on their 7 day admission and at their 3-month outpatient follow-up (8 total days).

Study Arms (2)

Delayed mobilization (DeM)

EXPERIMENTAL

Active therapy beginning ≥3 days from stroke symptom onset.

Other: Delayed mobilization (DeM)

Standard care

ACTIVE COMPARATOR

Allied health assessment by 48 hours post-stroke followed by initiation of therapy at routine intensity (approximately 20 minutes/day of occupational and 20 minutes/day of physiotherapy). Therapy will depend on the level of disability of the participant, but will include working on standing, stepping, walking, balancing, self-care (i.e., grooming, dressing), functional task training (i.e., self-feeding), and addressing any cognitive and/or perceptive deficits.

Other: Standard Care (in control arm)

Interventions

Delayed mobilization (group 1): active therapy beginning ≥3 days from symptom onset.

Also known as: Standard care
Delayed mobilization (DeM)

Standard care (group 2): allied health assessment by 48 hours post-stroke followed by initiation of therapy at routine intensity (approximately 20 minutes/day of occupational and 20 minutes/day of physiotherapy). Therapy will depend on the level of disability of the participant, but will include working on standing, stepping, walking, balancing, self-care (i.e., grooming, dressing), functional task training (i.e., self-feeding), and addressing any cognitive and/or perceptive deficits. Active therapy will be conducted by the Foothills Medical Centre stroke unit (Calgary, AB, Canada) certified physiotherapists and occupational therapists. The allied health team will not be blinded to the randomization of participants.

Standard care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants with acute ischemic stroke presenting to Foothills Medical Centre meeting eligibility for intravenous thrombolysis (Tenecteplase, TNK) - ≥18 years of age presenting within 4.5 hours of symptom onset with a diagnosis of suspected acute ischemic stroke causing significant neurological disability - and/or endovascular thrombectomy (EVT).
  • Age ≥18 years.
  • Persistent vessel occlusion will be defined as any of the following:
  • EVT treatment of medium or large intracranial vessel occlusion with a thrombolysis in cerebral infarction (TICI) score of ≤2b.
  • A moderate infarct core (ASPECTS ≤5) despite TICI 3.
  • hour CT with evidence of hyperdense sign appropriate to clinical deficits.

You may not qualify if:

  • Comorbid conditions limiting recovery or life expectancy (e.g., significant cognitive impairment, stage IV cancer, end-stage renal disease).
  • Low pre-stroke baseline functional status (mRS ≥4).
  • Symptoms due to another acute neurological condition (e.g., migraine with aura, seizure) or neurological deficits secondary to metabolic/toxic derangements (e.g., hyponatremia, hypoglycemia).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Foothills Medical Centre

Calgary, Alberta, T2N 2T9, Canada

Location

MeSH Terms

Conditions

StrokeIschemic Stroke

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participants will be assigned to the control or experimental group using a 1:1 computer-generated randomized dynamic allocation procedure. All members of the research team will be blinded to group allocation. Participants and allied health team members (physiotherapist, occupational therapist, nursing) will not be blinded but will be asked not to tell the assessor or other participants which group they have been allocated to, in order to preserve blinding of the assessments. The study statistician and the rest of the Data Safety Monitoring Board will have access to the assignment if necessary.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomized into one of two groups after admission to hospital: 1. Delayed care (group 1): active therapy beginning ≥3 days from symptom onset. 2. Standard care (group 2): allied health assessment by 48 hours post-stroke followed by initiation of therapy at routine intensity (approximately 20 minutes/day of occupational and 20 minutes/day of physiotherapy). Therapy will depend on the level of disability of the participant, but will include working on standing, stepping, walking, balancing, self-care (i.e., grooming, dressing), functional task training (i.e., self-feeding), and addressing any cognitive and/or perceptive deficits.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, MSc

Study Record Dates

First Submitted

September 23, 2025

First Posted

October 8, 2025

Study Start

October 15, 2025

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

October 8, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations